Physician profile
Simi M Koshy
NPI 1346533841
$7,565.30
in general payments reported to CMS, 2019-2025
52 companies · $632 in 2025
The $632 reported for 2025 was more than what 78% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,870 · 2020: $788 · 2021: $1,266 · 2022: $1,305 · 2023: $774 · 2024: $931 · 2025: $632.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,337.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,336.72 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,072.06 | 2021-2025 | |
| Lilly USA, LLC | $828.89 | 2019-2025 | Jardiance, Mounjaro, Zepbound |
| Takeda Pharmaceuticals U.S.A., INC. | $646.72 | 2019-2025 | Trintellix |
| Astrazeneca Pharmaceuticals Lp | $628.71 | 2019-2025 | Airsupra, Farxiga, Breztri |
| Novo Nordisk INC | $574.11 | 2019-2025 | Ozempic, Rybelsus |
| Sanofi-Aventis U.S. LLC | $352.25 | 2019-2023 | |
| Glaxosmithkline, LLC. | $346.14 | 2019-2024 | Trelegy Ellipta, Shingrix |
| Boehringer Ingelheim Pharmaceuticals, INC. | $281.37 | 2019-2022 | |
| Dexcom, INC. | $281.02 | 2024-2025 | Dexcom G6 Transmitter |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $236.84 | 2019-2024 | Xifaxan |
| Janssen Pharmaceuticals, INC | $207.80 | 2019-2023 | Spravato |
| Abbott Laboratories | $195.03 | 2020-2024 | Freestyle Libre 3, Proclaim |
| Allergan, INC. | $184.79 | 2019-2020 | |
| Pfizer INC. | $182.81 | 2019-2025 | |
| Amgen INC. | $154.66 | 2019-2025 | Repatha, Otezla, Otezla |
Show all 52 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Simi Koshy listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.